Edition:
United States

Core Laboratories NV (CLB.N)

CLB.N on New York Stock Exchange

97.51USD
22 Sep 2017
Change (% chg)

$0.92 (+0.95%)
Prev Close
$96.59
Open
$96.23
Day's High
$97.61
Day's Low
$96.11
Volume
133,170
Avg. Vol
171,469
52-wk High
$125.83
52-wk Low
$86.55

Chart for

About

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of... (more)

Overall

Beta: 1.62
Market Cap(Mil.): $4,303.91
Shares Outstanding(Mil.): 44.14
Dividend: 0.55
Yield (%): 2.26

Financials

  Industry Sector
P/E (TTM): -- 131.69 16.08
EPS (TTM): -- -- --
ROI: -- 2.99 14.60
ROE: -- 4.26 14.03

BRIEF-Core Laboratories Q2 profit of 52 cents/shr

* Core Laboratories NV - q2 2017 revenue of $163.9 million, up 4 pct sequentially from its q1 2017 revenue

Jul 24 2017

Greenlight's Einhorn calls Core Labs shares 'way overvalued'

NEW YORK Billionaire investor David Einhorn on Monday called energy services provider Core Laboratories substantially overvalued and said its share price could drop to $62.

May 08 2017

Greenlight's Einhorn calls Core Labs shares 'way overvalued'

NEW YORK, May 8 Billionaire investor David Einhorn on Monday called energy services provider Core Laboratories substantially overvalued and said its share price could drop to $62.

May 08 2017

BRIEF-Core Laboratories CEO David Demshur's 2016 total compensation was $6.2 mln

* CEO David Demshur's fy 2016 total compensation was $6.2 million versus $6.6 million in fy 2015 - sec filing Source text: [http://bit.ly/2oer7bh] Further company coverage:

Mar 24 2017

Earnings vs. Estimates